125 related articles for article (PubMed ID: 36822333)
1. Combinatory in vitro effects of the β2-agonists salbutamol and formoterol in skeletal muscle cells.
Piribauer M; Jiang L; Kostov T; Parr M; Steidel S; Bizjak DA; Steinacker JM; Diel P
Toxicol Lett; 2023 Apr; 378():10-18. PubMed ID: 36822333
[TBL] [Abstract][Full Text] [Related]
2. Testing anabolic activity, potency and mechanisms of action of the phyto-derived beta 2 agonist higenamine.
Jiang L; Piribauer M; Kostov T; Steidel S; Bizjak DA; Steinacker JM; Parr M; Diel P
Toxicol Lett; 2023 Aug; 385():21-28. PubMed ID: 37598871
[TBL] [Abstract][Full Text] [Related]
3. β
Jessen S; Reitelseder S; Kalsen A; Kreiberg M; Onslev J; Gad A; Ørtenblad N; Backer V; Holm L; Bangsbo J; Hostrup M
J Appl Physiol (1985); 2021 Mar; 130(3):617-626. PubMed ID: 33357007
[TBL] [Abstract][Full Text] [Related]
4. Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size.
Hagg A; Colgan TD; Thomson RE; Qian H; Lynch GS; Gregorevic P
Sci Rep; 2016 Mar; 6():23042. PubMed ID: 26972746
[TBL] [Abstract][Full Text] [Related]
5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.
Pearen MA; Ryall JG; Lynch GS; Muscat GE
BMC Genomics; 2009 Sep; 10():448. PubMed ID: 19772666
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
8. Beta
Hostrup M; Reitelseder S; Jessen S; Kalsen A; Nyberg M; Egelund J; Kreiberg M; Kristensen CM; Thomassen M; Pilegaard H; Backer V; Jacobson GA; Holm L; Bangsbo J
J Physiol; 2018 Sep; 596(17):4121-4139. PubMed ID: 29968301
[TBL] [Abstract][Full Text] [Related]
9. Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism.
McCormick C; Alexandre L; Thompson J; Mutungi G
J Appl Physiol (1985); 2010 Dec; 109(6):1716-27. PubMed ID: 20864554
[TBL] [Abstract][Full Text] [Related]
10. Anabolic and lipolytic actions of beta
Hostrup M; Jacobson GA; Jessen S; Lemminger AK
Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
[TBL] [Abstract][Full Text] [Related]
11. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
[TBL] [Abstract][Full Text] [Related]
12. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.
Advenier C; Qian Y; Koune JD; Molimard M; Candenas ML; Naline E
Br J Pharmacol; 1992 Apr; 105(4):792-8. PubMed ID: 1354535
[TBL] [Abstract][Full Text] [Related]
13. Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms.
Ngala RA; O'Dowd J; Wang SJ; Agarwal A; Stocker C; Cawthorne MA; Arch JR
Br J Pharmacol; 2008 Oct; 155(3):395-406. PubMed ID: 18552870
[TBL] [Abstract][Full Text] [Related]
14. Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi.
Molimard M; Naline E; Zhang Y; Le Gros V; Begaud B; Advenier C
Eur Respir J; 1998 Mar; 11(3):583-8. PubMed ID: 9596106
[TBL] [Abstract][Full Text] [Related]
15. Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting
Szlenk CT; Gc JB; Natesan S
Mol Pharmacol; 2021 Oct; 100(4):406-427. PubMed ID: 34334369
[TBL] [Abstract][Full Text] [Related]
16. Formoterol, fenoterol, and salbutamol as partial agonists for relaxation of maximally contracted guinea pig tracheae: comparison of relaxation with receptor binding.
Lemoine H; Overlack C; Köhl A; Worth H; Reinhardt D
Lung; 1992; 170(3):163-80. PubMed ID: 1351970
[TBL] [Abstract][Full Text] [Related]
17. Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.
Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
J Pharmacol Sci; 2008 Aug; 107(4):393-400. PubMed ID: 18678986
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
19. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
